JP MORGAN/PUT/PFIZER INC/24/0.1/21.03.25 | Delayed Börse Stuttgart 05:00:44 2024-07-11 EDT | ||
| 0.071 EUR | -20.22% |
|
| Current month | -23.66% | ||
| 1 month | -14.46% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
PFIZER, INC.
| Date | Price | Change |
|---|---|---|
| 24-07-11 | 0.071 | -20.22% |
| 24-07-10 | 0.089 | +7.23% |
| 24-07-09 | 0.083 | +5.06% |
| 24-07-08 | 0.079 | -9.20% |
| 24-07-05 | 0.087 | +2.35% |
Delayed Quote Börse Stuttgart
Last update July 11, 2024 at 05:00 am
More quotesStatic data
| Product type | Plain-Vanilla-Warrants |
|---|---|
| Buy / Sell | PUT |
| Underlying | PFIZER, INC. |
| Issuer | J.P. Morgan |
| WKN | JB2GU5 |
| ISIN | DE000JB2GU59 |
| Date issued | 2023-09-29 |
| Strike | 24 $ |
| Maturity | 2025-03-21 (253 Days) |
| Parity | 10 : 1 |
| Emission price | 0.11 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 0.25 € |
|---|---|
| Lowest since issue | 0.064 € |
| Spread | 0.01 € |
| Spread % | 12.66% |
Company Profile
Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows:
- primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.;
- specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.;
- oncology products (12.1%);
- other (1.3%).
At the end of 2022, the group had more than 35 manufacturing sites worldwide.
Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Sector
-
Consensus: Pfizer, Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
24
Last Close Price
28.66
USD
Average target price
32.01
USD
Spread / Average Target
+11.68%
- Stock Market
- Warrants
- Warrant
